VERIGRAFT makes transplantation possible without the severe risks of immunosuppression, and uses regenerative medicine technology to address so far incurable diseases.

The company is a pioneer in the field of regenerative medicine, developing personalized human tissues for transplantation. The current focus area is the development of fully biological, personalized blood vessels that can be used to replace diseased or non-functioning blood vessels in patients.